Skip to main content
Molecular & Cellular Proteomics

Main menu

  • Home
  • Articles
    • Current Issue
    • Papers in Press
    • Reviews and Minireviews
    • Special Issues
    • Editorials
    • Archive
    • Letters to the Editor (eLetters)
  • Info for
    • Authors
      • Editorial Policies
      • How to Submit
      • Manuscript Contents & Organization
      • Data Reporting Requirements
      • Publication Charges
    • Reviewers
    • Librarians
    • Advertisers
    • Subscribers
  • Guidelines
    • Proteomic Identification
      • Checklist (PDF)
      • Instructions for Annotated Spectra
      • Tutorial (PDF)
    • Clinical Proteomics
      • Checklist (PDF)
    • Glycomic Identification
      • Checklist (PDF)
    • Targeted Proteomics
      • Checklist (PDF)
    • Data-Independent Acquisition
      • Checklist (PDF)
    • Frequently Asked Questions
  • About
    • Mission Statement and Scope
    • Editorial Policies
    • Editorial Board
    • MCP Lectureships
    • Permissions and Licensing
    • Partners
    • Alerts
    • Contact Us

Submit

  • Submit
  • Publications
    • ASBMB
    • Molecular & Cellular Proteomics
    • Journal of Biological Chemistry
    • Journal of Lipid Research

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
  • Publications
    • ASBMB
    • Molecular & Cellular Proteomics
    • Journal of Biological Chemistry
    • Journal of Lipid Research
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Molecular & Cellular Proteomics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Papers in Press
    • Reviews and Minireviews
    • Special Issues
    • Editorials
    • Archive
    • Letters to the Editor (eLetters)
  • Info for
    • Authors
      • Editorial Policies
      • How to Submit
      • Manuscript Contents & Organization
      • Data Reporting Requirements
      • Publication Charges
    • Reviewers
    • Librarians
    • Advertisers
    • Subscribers
  • Guidelines
    • Proteomic Identification
      • Checklist (PDF)
      • Instructions for Annotated Spectra
      • Tutorial (PDF)
    • Clinical Proteomics
      • Checklist (PDF)
    • Glycomic Identification
      • Checklist (PDF)
    • Targeted Proteomics
      • Checklist (PDF)
    • Data-Independent Acquisition
      • Checklist (PDF)
    • Frequently Asked Questions
  • About
    • Mission Statement and Scope
    • Editorial Policies
    • Editorial Board
    • MCP Lectureships
    • Permissions and Licensing
    • Partners
    • Alerts
    • Contact Us
  • Submit
Special Issue: Post-translational Modifications

Alpha-synuclein Post-translational Modifications as Potential Biomarkers for Parkinson Disease and Other Synucleinopathies

Adrien W. Schmid, Bruno Fauvet, Marc Moniatte and Hilal A. Lashuel
Molecular & Cellular Proteomics December 1, 2013, First published on August 21, 2013, 12 (12) 3543-3558; https://doi.org/10.1074/mcp.R113.032730
Adrien W. Schmid
From the ‡Proteomics Core Facility, School of Life Sciences, Station 19, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruno Fauvet
¶Laboratory of Molecular and Chemical Biology of Neurodegeneration, Station 19, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Moniatte
From the ‡Proteomics Core Facility, School of Life Sciences, Station 19, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hilal.lashuel@epfl.ch marc.moniatte@epfl.ch
Hilal A. Lashuel
¶Laboratory of Molecular and Chemical Biology of Neurodegeneration, Station 19, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hilal.lashuel@epfl.ch marc.moniatte@epfl.ch
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Post-translational modifications of α-syn. A, the locations of the main α-syn PTMs (phosphorylation, ubiquitination, nitration, and truncation) are shown. Disease-associated PTMs identified in Lewy bodies are shown in the upper part of the scheme, and those identified from in vitro studies are shown below. Green bars above and below the sequence of α-syn show epitope maps of the most frequently used non-PTM and non-oligomer-specific antibodies for immunoassay-based α-syn quantification in the CSF and blood plasma. Stars indicate putative or incomplete epitope mapping. B, dot blot showing evidence that PTMs can interfere with the detection of modified α-syn by antibodies. Using the Syn-211 clone, the sensitivity for pY125 α-syn was reduced, and double-phosphorylated α-syn (pY125/pS129) was nearly undetected. The antibodies used for detection are shown on the right-hand side of the blots. C, schemes depicting the ordinary, α-syn monomer-directed ELISA assays (left) and the principle of the oligomer-specific ELISA system (right). Adapted from Ref. 23.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Epitope mapping of α-syn antibodies. Monoclonal and polyclonal antibodies are shown in green and red, respectively. Residue numbers corresponding to the epitopes are shown in bold (when available).

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Chemical protein synthesis as a tool to generate well-defined full-length protein standards for absolute quantification. A, mechanism of the native chemical ligation reaction, a core component of chemical protein synthesis approaches. B, expressed protein ligation can be combined with enzymatic modifications using specific enzymes, such as PLK3, thus allowing the preparation of α-syn modified at multiple residues to enable investigation of how single or multiple PTMs influence α-syn detection by different antibodies and comparison of the performance of mass-spectrometry-based quantification to the immunoassays currently in use. Adapted from Ref. 58. C, total chemical synthesis of α-syn using three fragments, all produced via chemical peptide synthesis, allowing the introduction of PTMs and/or various labels (shown as colored stars) anywhere within the α-syn′ sequence (whereas semisynthesis, shown in B, is mostly restricted to PTMs within the C or N terminus of α-syn). The central fragment (green) initially bears a temporary thiazolidine (Thz) protection to prevent the peptide from polymerizing and/or undergoing cyclization. Adapted from Ref. 131. D, immunocytochemistry (left) and Western blot (right) show that pY125 is a very labile modification, highlighting that the semisynthetic pY125 α-syn standard can be very useful for developing protocols to stabilize this modification in biological samples.

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Overview of the main workflow from sample preparation to MS analysis. The diagram outlines the required workflow for sample preparation prior to MS analysis and quantification via selected reaction monitoring (SRM). Total protein extraction is typically carried out by means of SDS followed by protein equalization using a BCA assay. Prior to processing, protein extracts are spiked with a full-length heavy isoform 15N α-syn protein carrying the PTM of interest such as nitration (3NT) or phosphorylation at tyrosine or serine residues. Samples are typically fractionated via isoelectric focusing (IEF), SDS-PAGE, or size-exclusion chromatography (SEC). Following fractionation, samples are digested by trypsin (Tryp), Asp-N, cyanogen bromide (CNBr), or Glu-C using consecutive or combined digestions. Gel bands are extracted at the migration height of α-syn protein and subjected to individual proteolysis. For combined proteolytic analysis, such as in the case of Tryp and Glu-C digestions, samples are run in duplicate and digested separately or sequentially as in the case of Tryp and Asp-N proteolysis. Phosphopeptide enrichment (i.e. using titanium dioxide (TiO2)) chromatography allows for the enrichment of pathologically relevant phosphorylated peptides such as at residues p-S87, p-Y125, and p-S129. If full-length protein standards are not available, then the use of synthetic heavy-labeled surrogate peptides (AQUA) allows for individual spiking of reference peptides bearing PTMs of particular interest. Following proteolysis and reference peptide spiking, samples are analyzed via liquid chromatography (LC) coupled with SRM.

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    Proteolytic peptides typically observed via mass spectrometry following trypsin (A), Glu-C (B), cyanogen bromide (C), and Asp-N (D) digestion. (MS preferential peptides are highlighted in red.) E, liquid chromatography MS spectrum of a typical LC-SRM analysis of α-syn tryptic and Glu-C peptides derived from rat nigral tissue. Endogenous rat syn (black) and viral induced overexpressed human α-syn (red) can be quantified during a single LC-SRM run. F, zoom of the highlighted area in E showing the total ion extraction chromatogram of tryptic fragment 81–96 with its heavy-labeled α-syn isoform (15N) below. A shift in retention time can be observed between rat and human isoforms accounting for the difference in sequence at residue 87 or for the phosphorylation occurring at p-S87, whereas the retention time of surrogate peptides (15N heavy isoform) corresponds to the endogenous form.

PreviousNext
Back to top
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Molecular & Cellular Proteomics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Alpha-synuclein Post-translational Modifications as Potential Biomarkers for Parkinson Disease and Other Synucleinopathies
(Your Name) has sent you a message from Molecular & Cellular Proteomics
(Your Name) thought you would like to see the Molecular & Cellular Proteomics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Alpha-synuclein Post-translational Modifications as Potential Biomarkers for Parkinson Disease and Other Synucleinopathies
Adrien W. Schmid, Bruno Fauvet, Marc Moniatte, Hilal A. Lashuel
Molecular & Cellular Proteomics December 1, 2013, First published on August 21, 2013, 12 (12) 3543-3558; DOI: 10.1074/mcp.R113.032730

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Request Permissions

Share
Alpha-synuclein Post-translational Modifications as Potential Biomarkers for Parkinson Disease and Other Synucleinopathies
Adrien W. Schmid, Bruno Fauvet, Marc Moniatte, Hilal A. Lashuel
Molecular & Cellular Proteomics December 1, 2013, First published on August 21, 2013, 12 (12) 3543-3558; DOI: 10.1074/mcp.R113.032730
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

In this issue

Molecular & Cellular Proteomics: 12 (12)
Molecular & Cellular Proteomics
Vol. 12, Issue 12
1 Dec 2013
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • About the Cover
  • Index by author
  • Ed Board (PDF)

View this article with LENS

Jump to section

  • Article
    • Abstract
    • CONCLUDING REMARKS
    • Footnotes
    • REFERENCES
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

  • Follow MCP on Twitter
  • RSS feeds
  • Email

Articles

  • Current Issue
  • Papers in Press
  • Archive

For Authors

  • Submit a Manuscript
  • Info for Authors

Guidelines

  • Proteomic Identification
  • Clinical Proteomics
  • Glycomic Identification
  • Targeted Proteomics
  • Frequently Asked Questions

About MCP

  • About the Journal
  • Permissions and Licensing
  • Advertisers
  • Subscribers

ASBMB Publications

  • Molecular & Cellular Proteomics
  • Journal of Biological Chemistry
  • Journal of Lipid Research
  • ASBMB Today

© 2019 American Society for Biochemistry and Molecular Biology | Privacy Policy

MCP Print ISSN 1535-9476 Online ISSN 1535-9484

Powered by HighWire